{
    "Trade/Device Name(s)": [
        "Tina-quant Hemoglobin A1c Gen.2 assay",
        "HbA1c Gen.2"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K110313",
    "Predicate Device Reference 510(k) Number(s)": [
        "K072714"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "December 21, 2011",
    "Summary Letter Received Date": "December 22, 2011",
    "Submission Date": "January 31, 2011",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Hemolysate"
    ],
    "Specimen Container(s)": [
        "Li-Heparin tube",
        "K2-EDTA tube",
        "K3-EDTA tube",
        "KF/Na2-EDTA tube",
        "Na-Heparin tube",
        "NaF/K-Oxalate tube",
        "NaF/Na2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Integra 400",
        "Integra 400 plus",
        "Integra 800",
        "Integra 800 CTS"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric immunoinhibition (TINIA)",
        "Bichromatic photometric determination"
    ],
    "Methodologies": [
        "Immunoassay",
        "Photometric analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent system"
    ],
    "Document Summary": "FDA 510(k) summary for Tina-quant Hemoglobin A1c Gen.2 assay for quantitative determination of hemoglobin A1c in whole blood or hemolysate using Roche analyzers",
    "Indications for Use Summary": "Intended for quantitative determination of mmol/mol hemoglobin A1c (IFCC) and % hemoglobin A1c (DCCT/NGSP) in hemolysate or whole blood to monitor long-term blood glucose control in individuals with diabetes mellitus",
    "fda_folder": "Hematology"
}